Zydus Lifesciences Launches World’s First Biosimilar of Nivolumab Under the Brand Tishtha in India
Key Highlights: Implications: Tishtha detonates pricing bombs on...
Breaking developments shaping Indian pharma, biotech, and healthcare.
Fast, factual reporting on what just happened.
Updated continuously, without the clutter.
Key Highlights: Implications: Tishtha detonates pricing bombs on...
Key Highlights: Implications: Quality failures erode trust in...
Key Highlights: Implications: Jubilant catapults into top-tier...
Key Highlights: Implications: The appointment...
Key Highlights: Implications: Lantern’s Bengaluru expansion...
Key Highlights: Implications: Dr. Reddy’s grabs...
Key Highlights: Implications: PrecisionCHD taps India’s...
Key Highlights: Implications: Kashiv’s scaling...
Key Highlights: Implications: The CDSCO approval gives India...
Key Highlights: Implication: This financing model slashes...